Pages that link to "Q1058608"
Jump to navigation
Jump to search
The following pages link to primary sclerosing cholangitis (Q1058608):
Displayed 50 items.
- liver cirrhosis (Q147778) (← links)
- Elena Baltacha (Q232680) (← links)
- Walter Payton (Q963117) (← links)
- pericholangitis (Q18554731) (← links)
- Bacterial cholangitis causing secondary sclerosing cholangitis: a case report (Q21261885) (← links)
- Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer (Q22250922) (← links)
- Bile acid derivatives for people with primary sclerosing cholangitis (Q24186230) (← links)
- Pharmacological treatments for primary sclerosing cholangitis: a network meta-analysis (Q24193305) (← links)
- Bile acids for primary sclerosing cholangitis (Q24234678) (← links)
- Glucocorticosteroids for primary sclerosing cholangitis (Q24241009) (← links)
- D-penicillamine for primary sclerosing cholangitis (Q24244561) (← links)
- Glucocorticosteroids for primary sclerosing cholangitis (Q24246617) (← links)
- D-penicillamine for primary sclerosing cholangitis (Q24247834) (← links)
- Bile acids for primary sclerosing cholangitis (Q24248730) (← links)
- Glucocorticosteroids for primary sclerosing cholangitis (Q24250522) (← links)
- Cholangiocarcinoma complicating primary sclerosing cholangitis (Q24540424) (← links)
- Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis (Q24541353) (← links)
- Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis (Q24542418) (← links)
- Update on inflammatory bowel disease in patients with primary sclerosing cholangitis (Q24567496) (← links)
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis (Q24655731) (← links)
- The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis (Q24792938) (← links)
- Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634] (Q24793791) (← links)
- Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management (Q26744040) (← links)
- Controversies in the management of primary sclerosing cholangitis (Q26765804) (← links)
- A review of the medical treatment of primary sclerosing cholangitis in the 21st century (Q26771816) (← links)
- Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective (Q26781780) (← links)
- How Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed? (Q26782878) (← links)
- Primary sclerosing cholangitis: diagnosis and treatment (Q26829216) (← links)
- Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity? (Q26994675) (← links)
- Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis (Q27012912) (← links)
- Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management (Q27015831) (← links)
- Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review (Q27024273) (← links)
- IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis (Q27478109) (← links)
- Autoantibodies in primary sclerosing cholangitis (Q27489093) (← links)
- (Q27674740) (redirect page) (← links)
- Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: an Update on MR Imaging Findings with Recent Developments (Q28068585) (← links)
- The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood (Q28068996) (← links)
- Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC) (Q28076453) (← links)
- HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations (Q28137734) (← links)
- The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis (Q28211823) (← links)
- HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis (Q28235548) (← links)
- High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis (Q28237152) (← links)
- Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis (Q28243850) (← links)
- Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis (Q28263151) (← links)
- Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis (Q28290468) (← links)
- Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 (Q28943462) (← links)
- Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci (Q28943478) (← links)
- Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features (Q30234950) (← links)
- Imaging and clinical characteristics of focal atrophy of segments 2 and 3 in primary sclerosing cholangitis (Q30306853) (← links)
- Performance of magnetic resonance elastography in primary sclerosing cholangitis (Q30355206) (← links)